# Progression-free survival as surrogate end point for overall survival in clinical trials of HER2-targeted agents in HER2-positive metastatic breast cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/progression-free-survival-as-surrogate-end-point-for-overall-survival-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Stefan Michiels,Lina Pugliano,Sophie Marguet,Daniel Grun,Jana Barinoff,David Cameron,Melody Cobleigh,Angelo Di Leo,S. Johnston,Giulio Gasparini,Bella Kaufman,M Marty,Valentina Nekljudova,Shani Paluch–Shimon,F Penault–Llorca,Dennis J. Slamon,Charles L. Vogel,Gϋnter von Minckwitz,Marc Buyse,Martine Piccart |
| Citations | 60 |
| DOI | 10.1093/annonc/mdw132 |
| Fields | Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://academic.oup.com/annonc/article-pdf/27/6/1029/16701533/mdw132.pdf |
| OpenAlex ID | https://openalex.org/W2296665753 |
| PMID | 26961151 |
| Type | article |
| Year | 2016 |

## Paper authors

- [Sophie Marguet](https://scholariq.org/researchers/sophie-marguet/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)

## Paper topics

- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.